GFI vs. AQST
GFI (Gold Fields Limited) and AQST (Aquestive Therapeutics, Inc.) are both stocks. GFI operates in Gold (Basic Materials), while AQST operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, GFI returned 32.03%/yr vs -0.29%/yr for AQST. At a 0.06 correlation, their price movements are largely independent.
Performance
GFI vs. AQST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GFI achieves a -13.96% return, which is significantly higher than AQST's -35.45% return.
GFI
- 1D
- 1.67%
- 1M
- -18.49%
- YTD
- -13.96%
- 6M
- -13.63%
- 1Y
- 50.40%
- 3Y*
- 39.19%
- 5Y*
- 32.03%
- 10Y*
- 27.45%
AQST
- 1D
- -0.95%
- 1M
- 0.97%
- YTD
- -35.45%
- 6M
- -32.85%
- 1Y
- 25.98%
- 3Y*
- 22.65%
- 5Y*
- -0.29%
- 10Y*
- —
GFI vs. AQST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
GFI Gold Fields Limited | -13.96% | 240.42% | -6.27% | 44.90% | -2.61% | 23.33% | 43.02% | 89.47% | -2.70% |
AQST Aquestive Therapeutics, Inc. | -35.45% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | -7.62% | -58.14% |
Correlation
The correlation between GFI and AQST is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2018 | 0.06 |
Fundamentals
GFI:
$32.65B
AQST:
$511.28M
GFI:
$5.39
AQST:
-$0.61
GFI:
2.34
AQST:
9.42
GFI:
$13.98B
AQST:
$50.27M
GFI:
$7.34B
AQST:
$20.92M
GFI:
$8.04B
AQST:
-$53.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GFI vs. AQST — Risk / Return Rank
GFI
AQST
GFI vs. AQST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Gold Fields Limited (GFI) and Aquestive Therapeutics, Inc. (AQST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GFI | AQST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.54 | ||
| Sortino ratioReturn per unit of downside risk | +0.30 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.16 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | 0.43 | +0.72 |
| Martin ratioReturn relative to average drawdown | 3.06 | 0.81 | +2.25 |
Loading charts...
Drawdowns
GFI vs. AQST - Drawdown Comparison
The maximum GFI drawdown since its inception was -88.05%, smaller than the maximum AQST drawdown of -96.68%. Use the drawdown chart below to compare losses from any high point for GFI and AQST.
Loading charts...
Drawdown Indicators
| GFI | AQST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.05% | -96.68% | +8.63% |
Max Drawdown (1Y)Largest decline over 1 year | -43.90% | -60.61% | +16.71% |
Max Drawdown (3Y)Largest decline over 3 years | -43.90% | -63.55% | +19.65% |
Max Drawdown (5Y)Largest decline over 5 years | -56.22% | -90.11% | +33.89% |
Max Drawdown (10Y)Largest decline over 10 years | -63.09% | — | — |
Current DrawdownCurrent decline from peak | -38.93% | -78.01% | +39.08% |
Average DrawdownAverage peak-to-trough decline | -44.25% | -76.92% | +32.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.51% | 32.01% | -15.50% |
Volatility
GFI vs. AQST - Volatility Comparison
The current volatility for Gold Fields Limited (GFI) is 17.70%, while Aquestive Therapeutics, Inc. (AQST) has a volatility of 21.51%. This indicates that GFI experiences smaller price fluctuations and is considered to be less risky than AQST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GFI | AQST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.70% | 21.51% | -3.81% |
Volatility (6M)Calculated over the trailing 6-month period | 46.40% | 68.41% | -22.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 59.94% | 85.07% | -25.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.37% | 82.62% | -30.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.90% | 87.69% | -32.79% |
Dividends
GFI vs. AQST - Dividend Comparison
GFI's dividend yield for the trailing twelve months is around 5.04%, while AQST has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GFI Gold Fields Limited | 5.04% | 1.77% | 2.94% | 2.87% | 3.40% | 3.24% | 1.72% | 0.81% | 1.61% | 1.41% | 1.35% | 0.60% |
Financials
GFI vs. AQST - Financials Comparison
This section allows you to compare key financial metrics between Gold Fields Limited and Aquestive Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GFI vs. AQST - Profitability Comparison
GFI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gold Fields Limited reported a gross profit of 3.00B and revenue of 5.29B. Therefore, the gross margin over that period was 56.7%.
AQST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 14.45M. Therefore, the gross margin over that period was 0.0%.
GFI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gold Fields Limited reported an operating income of 2.71B and revenue of 5.29B, resulting in an operating margin of 51.3%.
AQST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported an operating income of -4.20M and revenue of 14.45M, resulting in an operating margin of -29.1%.
GFI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gold Fields Limited reported a net income of 2.55B and revenue of 5.29B, resulting in a net margin of 48.2%.
AQST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a net income of -8.06M and revenue of 14.45M, resulting in a net margin of -55.8%.
Frequently Asked Questions
GFI and AQST have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AQST has higher volatility (21.51%) compared to GFI (17.70%). In terms of maximum drawdown, GFI dropped -88.05% vs AQST's -96.68%.
GFI currently has the higher Sharpe Ratio (0.85 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GFI and AQST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer